Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02099123 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)

Study acronym: STAREE
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Secondary endpoints: 15 to 16v10 See this version in full on ClinicalTrials.gov ↗
  2. Primary completion date: Dec 2022 to Dec 2025 Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 9631 to confirmed 9971 · Site details revised at 6 of 6 sitesv9 Show 3 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 9631 to confirmed 9971
    • Site details revised at 6 of 6 sites
  3. Enrollment target: 18000 to 9631 Primary endpoints: 1 to 2 · Eligibility criteria shortened, about 13 words · Secondary endpoints: 12 to 15v8 Show 3 more changesShow less
    • Primary endpoints: 1 to 2
    • Eligibility criteria shortened, about 13 words
    • Secondary endpoints: 12 to 15

    See this version in full on ClinicalTrials.gov ↗

  4. Completion date: Dec 2023 to Dec 2025v7
  5. Trial status: Enrolling by Invitation to Recruiting Study sites: 5 to 6 · Completion date: Dec 2022 to Dec 2023 · Secondary endpoints revised (12) · 1 morev6 Show 4 more changesShow less
    • Study sites: 5 to 6
    • Completion date: Dec 2022 to Dec 2023
    • Secondary endpoints revised (12)
    • Collaborators: 1 to 2

    See this version in full on ClinicalTrials.gov ↗

Show 4 earlier versionsHide 4 earlier versions
  1. Primary and study completion dates: Dec 2020 to Dec 2022 Study sites: 4 to 5v5 Show 1 more changeShow less
    • Study sites: 4 to 5
  2. Primary endpoint revised Study sites: 2 to 4 · Eligibility criteria expanded, about 157 words · Secondary endpoints: 8 to 12v4 Show 3 more changesShow less
    • Study sites: 2 to 4
    • Eligibility criteria expanded, about 157 words
    • Secondary endpoints: 8 to 12

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Enrolling by Invitation Primary and study completion dates: Dec 2019 to Dec 2020 · Start date: May 2015 to Jul 2015 · Study sites: 0 to 2 · 1 morev3 Show 4 more changesShow less
    • Primary and study completion dates: Dec 2019 to Dec 2020
    • Start date: May 2015 to Jul 2015
    • Study sites: 0 to 2
    • Secondary endpoints: details revised at 1 of 8 entries
  4. Enrollment target: 12000 to 18000 Start date: Dec 2014 to May 2015v2 Show 1 more changeShow less
    • Start date: Dec 2014 to May 2015
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The STAREE study will examine whether treatment with statin (atorvastatin 40mg) compared with placebo will prolong disability free survival and reduce major cardiovascular events amongst healthy elderly people (≥70 years).
Trial Details
NCT Number NCT02099123
Lead Sponsor Monash University
Collaborators: National Health and Medical Research Council, Australia, National Heart Foundation, Australia
Conditions Independent Living, Disability Free Survival, Elderly, Healthy
Enrollment 9,971 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov